Vivos Therapeutics Inc (VVOS) Stock Price, Quote & News

Company Profile

Vivos Therapeutics, Inc. operates as a medical technology company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children....

Industry: Medical Devices

Sector: Healthcare

Phone: 844 672 4357

Website: www.vivos.com

Address:

7921 Southpark Plaza, Suite 210, Littleton, United States

Loopi Mar. 20 at 11:33 PM

$VVOS short term target is $0.46

0 · Reply

Loopi Mar. 20 at 11:05 PM

$VVOS Offering or spilt first??

0 · Reply

Loopi Mar. 20 at 11:04 PM

$VVOS under $1 by next month very bearish driven by scams

0 · Reply

Giovannirs3 Mar. 20 at 8:11 PM

$VVOS 👍👌🤣

0 · Reply

Giovannirs3 Mar. 20 at 7:12 PM

$VVOS 👌🤣

0 · Reply

Giovannirs3 Mar. 20 at 7:12 PM

$VVOS 🤣

0 · Reply

GamblerDan Mar. 20 at 7:08 PM

$VVOS Another weak hand just bailed on that 89k dump candle. Added more

1 · Reply

fibtrader99 Mar. 20 at 6:59 PM

$VVOS I know rate cuts are being priced out, the 10yr is closing in on 4.4 and the world looks to be ending, but if you could close this week green, I'd appreciate it.

0 · Reply

Giovannirs3 Mar. 20 at 5:07 PM

$VVOS 👍

0 · Reply

Giovannirs3 Mar. 20 at 2:11 PM

$VVOS 👌

0 · Reply

Recent Study Confirms Fundamental Correlation Between Severity of Obstructive Sleep Apnea and Oral Anatomy

Feb 5, 2026, 8:45 AM EST - 6 weeks ago

Vivos Therapeutics and SoundHealth Announce Collaboration to Expand Access to SoundHealth's Groundbreaking FDA-Cleared Allergy and Sleep Technologies

Feb 3, 2026, 6:23 AM EST - 6 weeks ago

Top 3 Health Care Stocks That Could Lead To Your Biggest Gains This Quarter

CERT ZLAB

Jan 20, 2026, 5:31 PM EST - 2 months ago

Vivos Therapeutics Announces Closing of Exercise of Warrants for $4.64 Million Gross Proceeds

Jan 16, 2026, 8:00 AM EST - 2 months ago

Vivos Therapeutics Announces Exercise of Warrants for $4.64 Million Gross Proceeds

Dec 16, 2025, 8:45 AM EST - 3 months ago

Vivos Therapeutics Announces Grand Opening of Affiliated Sleep Center Near Detroit, Michigan

Nov 19, 2025, 4:20 PM EST - 4 months ago

Vivos Therapeutics Reports Significant Revenue Growth During the Third Quarter 2025

Nov 19, 2025, 8:30 AM EST - 4 months ago

Vivos Therapeutics Schedules Release of Third Quarter 2025 Financial Results and Conference Call

Sep 30, 2025, 8:30 AM EDT - 6 months ago

Vivos Therapeutics Releases Additional Clinical Data Showing Marked Improvement in Pediatric ADHD from Use of Vivos DNA Device

Sep 17, 2025, 8:30 AM EDT - 6 months ago

Vivos Therapeutics Announces Landmark Clinical Trial Results in Pediatric Obstructive Sleep Apnea Treatment

Aug 19, 2025, 4:20 PM EDT - 7 months ago

Vivos Therapeutics Reports Second Quarter 2025 Financial Results and Provides Operational Update

Aug 19, 2025, 8:30 AM EDT - 7 months ago

Vivos Therapeutics Schedules Release of Second Quarter 2025 Financial Results and Conference Call

Jun 26, 2025, 8:30 AM EDT - 9 months ago

New Clinical Trial Data Published Showing Positive Results from Use of Vivos Technology to Treat Obstructive Sleep Apnea in Children

May 14, 2025, 9:15 AM EDT - 11 months ago

Vivos Therapeutics Schedules Release of First Quarter 2025 Financial Results and Conference Call

Apr 16, 2025, 8:30 AM EDT - 1 year ago

Vivos Therapeutics Signs Definitive Agreement to Acquire Largest Sleep Center Operator in Nevada

Mar 31, 2025, 4:20 PM EDT - 1 year ago

Vivos Therapeutics Reports Full Year 2024 Financial Results and Provides Operational Update

Mar 28, 2025, 8:30 AM EDT - 1 year ago

Vivos Therapeutics Schedules Release of Full Year 2024 Financial Results and Conference Call

Dec 23, 2024, 8:00 AM EST - 1 year ago

Vivos Therapeutics Announces $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Nov 13, 2024, 5:00 PM EST - 1 year ago

Vivos Therapeutics Schedules Release of Third Quarter 2024 Financial Results and Conference Call

Oct 8, 2024, 7:30 AM EDT - 1 year ago

Vivos Therapeutics Granted CPT® Coverage and Reimbursement Codes for All Vivos CARE Oral Medical Devices From American Medical Association

Sep 18, 2024, 7:00 AM EDT - 1 year ago

Vivos Therapeutics Receives Groundbreaking FDA 510(k) Clearance to Treat Moderate to Severe Pediatric Sleep Apnea and Snoring

Aug 14, 2024, 4:05 PM EDT - 1 year ago

Vivos Therapeutics Reports Second Quarter 2024 Financial Results and Provides Operational Update

Aug 14, 2024, 7:30 AM EDT - 1 year ago

Vivos Therapeutics Schedules Release of Second Quarter 2024 Financial Results and Conference Call

Jun 27, 2024, 7:30 AM EDT - 1 year ago

Vivos Therapeutics Announces Positive Results From 7-Month Multi-Site Pilot of its New Provider-Based Marketing and Distribution Model

Jun 12, 2024, 7:30 AM EDT - 1 year ago

Vivos Therapeutics Closes $7.5 Million At-The-Market Private Equity-Backed Investment and Launches Strategic Marketing and Distribution Alliance

May 14, 2024, 4:05 PM EDT - 2 years ago

Vivos Therapeutics Reports First Quarter 2024 Financial Results and Provides Operational Update

May 14, 2024, 7:30 AM EDT - 2 years ago

Vivos Therapeutics Schedules Release of First Quarter 2024 Financial Results and Conference Call

Apr 9, 2024, 7:30 AM EDT - 2 years ago

Vivos Therapeutics' Flagship CARE Oral Medical Devices Receive Full Approval for Medicare Reimbursement

Mar 28, 2024, 4:05 PM EDT - 2 years ago

Vivos Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Operational Update

Mar 28, 2024, 7:30 AM EDT - 2 years ago

Vivos Therapeutics Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Conference Call

Feb 6, 2024, 7:30 AM EST - 2 years ago

Vivos Therapeutics Highlights Significant Favorable Market Developments Creating Exciting New Growth Opportunities

Jan 8, 2024, 7:30 AM EST - 2 years ago

Vivos Therapeutics Sees Positive Preliminary Metrics Following Unprecedented FDA 510(k) Clearance of the Company's Proprietary Oral Medical Devices to Treat Severe OSA

Dec 11, 2023, 7:30 AM EST - 2 years ago

Vivos Therapeutics Presents Groundbreaking Event: “Empowering Women to Champion Airway”

Nov 29, 2023, 11:09 AM EST - 2 years ago

Vivos Therapeutics' stock soars as sleep apnea device gets regulatory clearance

Nov 29, 2023, 7:44 AM EST - 2 years ago

US FDA clears Vivos Therapeutics' oral device treatment for sleep apnea

Nov 29, 2023, 7:30 AM EST - 2 years ago

Vivos Therapeutics Receives First Ever FDA 510(k) Clearance for Oral Device Treatment of Severe Obstructive Sleep Apnea

Nov 14, 2023, 4:05 PM EST - 2 years ago

Vivos Therapeutics Reports Third Quarter 2023 Financial Results and Provides Operational Update

Nov 9, 2023, 4:30 PM EST - 2 years ago

Vivos Therapeutics Schedules Release of Third Quarter 2023 Financial Results and Conference Call

Nov 2, 2023, 5:00 PM EDT - 2 years ago

Vivos Therapeutics Closes $4 Million Private Placement

Oct 26, 2023, 7:30 AM EDT - 2 years ago

Vivos Therapeutics Announces Reverse Stock Split

Oct 24, 2023, 7:30 AM EDT - 2 years ago

Vivos Therapeutics Signs Nationwide Distribution Agreement with Lincare

Oct 11, 2023, 7:30 AM EDT - 2 years ago

Vivos Therapeutics to Begin Clinical Trial at Stanford Medicine

Oct 5, 2023, 7:30 AM EDT - 2 years ago

Vivos Therapeutics Announces Strategic Collaboration in the Middle East-North Africa Region to Support International Expansion

Oct 4, 2023, 7:30 AM EDT - 2 years ago

Vivos Therapeutics Executes Strategic Agreements with Ormco and On Demand Orthodontist To Provide Spark™ Clear Aligners to Its National Network of Providers

Oct 2, 2023, 7:30 AM EDT - 2 years ago

New York Times Best-Selling Author James Nestor to Headline List of Speakers for Fifth Annual Vivos Breathing Wellness Conference

Aug 16, 2023, 4:05 PM EDT - 2 years ago

Vivos Therapeutics Reports Second Quarter 2023 Financial Results and Provides Operational Update

Aug 16, 2023, 7:30 AM EDT - 2 years ago

Vivos Therapeutics Reschedules Second Quarter 2023 Financial Results Conference Call

Aug 14, 2023, 5:06 PM EDT - 2 years ago

Vivos Therapeutics to Reschedule Second Quarter 2023 Financial Results Conference Call

Aug 10, 2023, 8:31 PM EDT - 2 years ago

Vivos Therapeutics Schedules Release of Second Quarter 2023 Financial Results and Conference Call

Jun 8, 2023, 4:05 PM EDT - 3 years ago

Vivos Therapeutics Reports First Quarter 2023 Financial Results and Provides Operational Update

Loopi Mar. 20 at 11:33 PM

$VVOS short term target is $0.46

0 · Reply

Loopi Mar. 20 at 11:05 PM

$VVOS Offering or spilt first??

0 · Reply

Loopi Mar. 20 at 11:04 PM

$VVOS under $1 by next month very bearish driven by scams

0 · Reply

Giovannirs3 Mar. 20 at 8:11 PM

$VVOS 👍👌🤣

0 · Reply

Giovannirs3 Mar. 20 at 7:12 PM

$VVOS 👌🤣

0 · Reply

Giovannirs3 Mar. 20 at 7:12 PM

$VVOS 🤣

0 · Reply

GamblerDan Mar. 20 at 7:08 PM

$VVOS Another weak hand just bailed on that 89k dump candle. Added more

1 · Reply

fibtrader99 Mar. 20 at 6:59 PM

$VVOS I know rate cuts are being priced out, the 10yr is closing in on 4.4 and the world looks to be ending, but if you could close this week green, I'd appreciate it.

0 · Reply

Giovannirs3 Mar. 20 at 5:07 PM

$VVOS 👍

0 · Reply

Giovannirs3 Mar. 20 at 2:11 PM

$VVOS 👌

0 · Reply

Giovannirs3 Mar. 20 at 2:10 PM

$VVOS 👇🤣➖️💯❤️

0 · Reply

Mad_Macks Mar. 20 at 3:31 AM

$VVOS still my top 2026 pik. What can I say except maybe I’m just a retard 🤷🏼‍♂️. I just love the clinical outcome and the business model and expect it to generate cash flow soon.

0 · Reply

Giovannirs3 Mar. 19 at 7:32 PM

$VVOS 🤣🤣🤣➖️💯❤️

0 · Reply

fibtrader99 Mar. 19 at 7:22 PM

$VVOS green close?

0 · Reply

golfguy42360 Mar. 19 at 5:55 PM

$VVOS Company needs to get the ball rolling I live in Philly not one of there sleep centers here none in PA. anywhere would have to drive to NJ. or Delaware.

1 · Reply

Giovannirs3 Mar. 19 at 2:28 PM

$VVOS 👇

0 · Reply

Loopi Mar. 19 at 1:27 PM

$VVOS Don’t even believe those posting here all fake accounts. This down and below $0.7 soon stay away 🖐🏻

0 · Reply

apple9 Mar. 19 at 11:00 AM

$VVOS The new website is worth taking a look at. http://Vivos.com you can evaluate yourself look at several videos and put your zip code in and get multiple locations for service.this appliance is perfect for the military

0 · Reply

skips200k Mar. 19 at 10:10 AM

$VVOS Just saying...Journal of Clinical Medicine supports Vivos’ long maintained belief that dental and facial morphology characterized by narrow palatal (upper) dental arches, high peaked palates, and recessed lower jaws were directly correlated to the prevalence and severity of obstructive sleep apnea (OSA) in adults and children.

0 · Reply

TickerBR Mar. 18 at 6:52 PM

$VVOS

0 · Reply

skips200k Mar. 18 at 6:34 PM

$VVOS buy b4 the run. Escalator down, Elevator UP.

0 · Reply

fibtrader99 Mar. 18 at 6:24 PM

$VVOS Fed leaves rates unchanged. 11-1 vote. Miran dissented (of course) 1 cut expected this year and 1 cut in 2027 Dot plot: 7 officials want to hold rates. 12 want 1 cut Powell speaks in 5 min

1 · Reply

Market Cap	14.03M
Revenue (ttm)	15.03M
Net Income (ttm)	-11.14M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-74.12%
Debt to Equity Ratio	3.45

Volume	202,800
Avg Vol	121,338
Day's Range	N/A - N/A
Shares Out	10.47M
Stochastic %K	10%
Beta	6.94
Analysts	Sell
Price Target	$5.00